1 |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组,中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版)[J]. 中华结核和呼吸杂志,2021, 44(3): 170-205.
|
2 |
任成山,王关嵩,钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
3 |
晏 妮,董俊康,张明周,等. 焦虑抑郁对慢性阻塞性肺疾病患者生活质量的影响及药物依从性中介作用[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(6): 771-775.
|
4 |
中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 成人社区获得性肺炎基层诊疗指南(2018年)[J]. 中华全科医师杂志,2019, 18(2): 117-126.
|
5 |
戴媛媛,马筱玲. 宏基因组二代测序技术在临床病原学诊断中的应用[J]. 临床检验杂志,2021, 39(1): 1-5.
|
6 |
缪 青,马玉燕,胡必杰. 基于宏基因二代测序技术检测呼吸道病毒的临床应用[J]. 中华医院感染学杂志,2018, 28(12): 1908-1912.
|
7 |
中华医学会呼吸病学分会. 肺部感染性疾病支气管肺泡灌洗病原体检测中国专家共识(2017年版)[J].中华结核和呼吸杂志,2017, 40(8): 578-583.
|
8 |
中华医学会细菌感染与耐药防治分会. 呼吸系统感染中宏基因组测序技术临床应用与结果解读专家共识[J]. 中华临床感染病杂志,2022, 15(2): 90-102.
|
9 |
Pires N, Pinto P, Marçal N, et al. Pharmacological treatment of COPD-New evidence[J]. Pulmonology, 2019, 25(2): 90-96.
|
10 |
Barker BL, Haldar K, Patel H, et al. Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations[J]. Chest, 2015, 147(1): 46-55.
|
11 |
Grudzinska FS, Aldridge K, Hughes S, et al. Early identification of severe community-acquired pneumonia: a retrospective observational study[J]. BMJ Open Respir Res, 2019, 6(1): e000438.
|
12 |
Mou S, Zhang W, Deng Y, et al. Comparison of CRP, procalcitonin,neutrophil counts, eosinophil counts, sTREM-1, and OPN between pneumonic and nonpneumonic exacerbations in COPD patients[J]. Can Respir J, 2022, 2022: 7609083.
|
13 |
Schuetz P, Beishuizen A, Broyles M, et al. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use[J]. Clin Chem Lab Med, 2019, 57(9): 1308-1318.
|
14 |
Kim YJ, Lim B, Kyung SY, et al. Comorbidity and inflammatory markers may contribute to predict mortality of high-risk patients with chronic obstructive pulmonary disease exacerbation[J]. J Clin Med Res, 2016, 8(7): 531-536.
|
15 |
Lanks CW, Musani AI, Hsia DW. Community-acquired pneumonia and hospital-acquired pneumonia[J]. Med Clin North Am, 2019, 103(3): 487-501.
|
16 |
Eshwara VK, Mukhopadhyay C, Rello J. Community-acquired bacterial pneumonia in adults: An update[J]. Indian J Med Res, 2020, 151(4): 287-302.
|
17 |
刘 策,叶 芳. 我国社区获得性肺炎病原学分布特点[J]. 中国医药导报,2016, 13(15): 55-58.
|
18 |
刘 青. 老年社区获得性肺炎临床特点及危险因素分析[J]. 中华医院感染学杂志,2013, 23(13): 3101-3103.
|
19 |
Lai YC, Lu MC, Hsueh PR. Hypervirulence and carbapenem resistance:two distinct evolutionary directions that led high-risk Klebsiella pneumoniae clones to epidemic success[J]. Expert Rev Mol Diagn, 2019, 19(9): 825-837.
|
20 |
Wark PA, Tooze M, Powell H, et al. Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission[J]. Respirology, 2013, 18(6): 996-1002.
|
21 |
Han D, Li Z, Li R, et al. mNGS in clinical microbiology laboratories:on the road to maturity[J]. Crit Rev Microbiol, 2019, 45(5-6): 668-685.
|
22 |
Chen X, Cao K, Wei Y, et al. Metagenomic next-generation sequencing in the diagnosis of severe pneumonias caused by Chlamydia psittaci[J]. Infection, 2020, 48(4): 535-542.
|
23 |
宋元林,张洪春,刘清泉,等. 重症社区获得性肺炎治疗的现状与展望[J]. 中华危重病急救医学,2019, 31(6): 665-668.
|
24 |
黄文杰,徐 虹,李伟峰,等. 初始细菌学检测在非重症社区获得性肺炎中的诊治价值[J]. 广东医学,2003, 24(1): 45-46.
|
25 |
Qu J, Zhang J, Chen Y, et al. Aetiology of severe community acquired pneumonia in adults identified by combined detection methods: a multi-centre prospective study in China[J]. Emerg Microbes Infect, 2022, 11(1): 556-566.
|
26 |
Klooster K, ten Hacken NH, Hartman JE, et al. [Bronchoscopic interventions in severe COPD: improvement of pulmonary function, exercise capacity and quality of life][J]. Ned Tijdschr Geneeskd, 2015, 159: A8497.
|
27 |
Zhu Y, Zheng X, Huang K, et al. Mortality prediction using clinical and laboratory features in elderly patients with severe community-acquired pneumonia[J]. Ann Palliat Med, 2021, 10(10): 10913-10921.
|
28 |
Gera K, Roshan R, Varma-Basil M, et al. Chronic pneumonia due to Klebsiella oxytoca mimicking pulmonary tuberculosis[J]. Pneumonol Alergol Pol, 2015, 83(5): 383-386.
|
29 |
邓晓慧,田 巍,葛晓竹,等. 纤维支气管镜吸痰联合肺泡灌洗对高龄慢性阻塞性肺疾病合并重症肺炎患者的疗效观察[J].中国医药,2021, 16(4): 535-539.
|
30 |
文富强,申永春. 基于线粒体动力学的慢性阻塞性肺疾病发病机制与保护策略[J]. 西南医科大学学报,2022, 45(5): 369-372.
|